MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank80
3Y CAGR+103.8%
5Y CAGR+201.8%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+103.8%/yr
Annual compound
5Y CAGR
+201.8%/yr
Recent deceleration
Percentile
P80
Within normal range
vs 5Y Ago
250.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$334.52M+85.4%
2024$180.43M-60.0%
2023$451.17M+1042.0%
2022$39.51M+391.4%
2021$8.04M+501.7%
2020$1.34M-